Gainers
- RayzeBio RYZB stock rose 98.2% to $60.6 during Tuesday's pre-market session. The company's market cap stands at $3.6 billion.
- Gracell Biotechnologies GRCL stock increased by 59.93% to $9.9. The market value of their outstanding shares is at $949.6 million.
- 60 Degrees SXTP stock increased by 54.15% to $1.39. The market value of their outstanding shares is at $8.0 million.
- IMAC Hldgs BACK shares rose 35.53% to $3.28. The company's market cap stands at $3.7 million.
- Brainstorm Cell BCLI stock moved upwards by 30.56% to $0.26. The market value of their outstanding shares is at $12.6 million.
- China Pharma Holding CPHI stock rose 20.91% to $0.14. The company's market cap stands at $4.6 million.
Losers
- Milestone Pharmaceuticals MIST stock decreased by 35.4% to $1.86 during Tuesday's pre-market session. The company's market cap stands at $62.2 million.
- SINTX Techs SINT shares decreased by 14.9% to $0.4. The company's market cap stands at $1.7 million.
- Panbela Therapeutics PBLA stock declined by 13.64% to $0.77. The market value of their outstanding shares is at $5.2 million.
- Jin Medical International ZJYL stock decreased by 10.97% to $122.01. The market value of their outstanding shares is at $945.5 million.
- Kiora Pharmaceuticals KPRX stock decreased by 10.95% to $0.48. The market value of their outstanding shares is at $3.6 million.
- Know Labs KNW shares declined by 9.25% to $0.53. The market value of their outstanding shares is at $42.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BCLIBrainstorm Cell Therapeutics Inc
$1.55-3.73%
CPHIChina Pharma Holding Inc
$0.2111-0.42%
KPRXKiora Pharmaceuticals Inc
$3.34-0.60%
MISTMilestone Pharmaceuticals Inc
$1.821.11%
PBLAPanbela Therapeutics Inc
$0.43004.88%
SINTSINTX Technologies Inc
$4.21-22.8%
SXTP60 Degrees Pharmaceuticals Inc
$2.046.18%
ZJYLJin Medical International Ltd
$0.79349.27%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in